Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 46

1.

The role of the MTHFR C677T polymorphism in methotrexate-induced toxicity in pediatric osteosarcoma patients.

Lambrecht L, Sleurs C, Labarque V, Dhooge C, Laenen A, Sinnaeve F, Renard M, Uyttebroeck A.

Pharmacogenomics. 2017 Jun;18(8):787-795. doi: 10.2217/pgs-2017-0013. Epub 2017 Jun 8.

PMID:
28592186
2.

Evaluation of timing of first vaccination in children after hematopoietic allogeneic stem cell transplantation.

Bauters T, Bordon Cueto De Braem V, Schelstraete P, Van Lancker S, Laureys G, Benoit Y, Dhooge C.

Eur J Oncol Nurs. 2016 Apr;21:212-4. doi: 10.1016/j.ejon.2015.10.006. Epub 2015 Nov 29.

PMID:
26645948
3.

Severe congenital neutropenia with neurological impairment due to a homozygous VPS45 p.E238K mutation: A case report suggesting a genotype-phenotype correlation.

Meerschaut I, Bordon V, Dhooge C, Delbeke P, Vanlander AV, Simon A, Klein C, Kooy RF, Somech R, Callewaert B.

Am J Med Genet A. 2015 Dec;167A(12):3214-8. doi: 10.1002/ajmg.a.37367. Epub 2015 Sep 11.

PMID:
26358756
4.

Impact of gender on efficacy and acute toxicity of alkylating agent -based chemotherapy in Ewing sarcoma: secondary analysis of the Euro-Ewing99-R1 trial.

van den Berg H, Paulussen M, Le Teuff G, Judson I, Gelderblom H, Dirksen U, Brennan B, Whelan J, Ladenstein RL, Marec-Berard P, Kruseova J, Hjorth L, Kühne T, Brichard B, Wheatley K, Craft A, Juergens H, Gaspar N, Le Deley MC; Euro-EWING99 Group.

Eur J Cancer. 2015 Nov;51(16):2453-64. doi: 10.1016/j.ejca.2015.06.123. Epub 2015 Aug 10.

PMID:
26271204
5.

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.

Bielack SS, Smeland S, Whelan JS, Marina N, Jovic G, Hook JM, Krailo MD, Gebhardt M, Pápai Z, Meyer J, Nadel H, Randall RL, Deffenbaugh C, Nagarajan R, Brennan B, Letson GD, Teot LA, Goorin A, Baumhoer D, Kager L, Werner M, Lau CC, Sundby Hall K, Gelderblom H, Meyers P, Gorlick R, Windhager R, Helmke K, Eriksson M, Hoogerbrugge PM, Schomberg P, Tunn PU, Kühne T, Jürgens H, van den Berg H, Böhling T, Picton S, Renard M, Reichardt P, Gerss J, Butterfass-Bahloul T, Morris C, Hogendoorn PC, Seddon B, Calaminus G, Michelagnoli M, Dhooge C, Sydes MR, Bernstein M; EURAMOS-1 investigators.

J Clin Oncol. 2015 Jul 10;33(20):2279-87. doi: 10.1200/JCO.2014.60.0734. Epub 2015 Jun 1.

6.

EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment.

Whelan JS, Bielack SS, Marina N, Smeland S, Jovic G, Hook JM, Krailo M, Anninga J, Butterfass-Bahloul T, Böhling T, Calaminus G, Capra M, Deffenbaugh C, Dhooge C, Eriksson M, Flanagan AM, Gelderblom H, Goorin A, Gorlick R, Gosheger G, Grimer RJ, Hall KS, Helmke K, Hogendoorn PC, Jundt G, Kager L, Kuehne T, Lau CC, Letson GD, Meyer J, Meyers PA, Morris C, Mottl H, Nadel H, Nagarajan R, Randall RL, Schomberg P, Schwarz R, Teot LA, Sydes MR, Bernstein M; EURAMOS collaborators.

Ann Oncol. 2015 Feb;26(2):407-14. doi: 10.1093/annonc/mdu526. Epub 2014 Nov 24.

7.

Practical considerations in the use of intravenous tacrolimus in hematopoietic stem cell transplantation patients.

Bauters T, Rayner P, Therrien R, Van Lancker S, Bordon V, Le Cordroch M, Dhooge C, Benoit Y, Vandenbroucke J.

J Oncol Pharm Pract. 2015 Dec;21(6):478-80. doi: 10.1177/1078155214531609. Epub 2014 Apr 18. No abstract available.

PMID:
24748582
8.

Administration of budesonide in children with graft-versus-host disease.

Bauters T, Rayner P, Therrien R, Van Lancker S, Bordon V, Robays H, Benoit Y, Dhooge C.

J Oncol Pharm Pract. 2014 Aug;20(4):316-8. doi: 10.1177/1078155213503591. Epub 2013 Sep 18. No abstract available.

PMID:
24047699
9.

Longitudinal linear growth and final height is impaired in childhood acute lymphoblastic leukemia survivors after treatment without cranial irradiation.

Vandecruys E, Dhooge C, Craen M, Benoit Y, De Schepper J.

J Pediatr. 2013 Jul;163(1):268-73. doi: 10.1016/j.jpeds.2012.12.037. Epub 2013 Jan 23.

PMID:
23351599
10.

Long-term outcomes of hematopoietic stem cell transplantation for severe treatment-resistant autoimmune cytopenia in children.

Rabusin M, Snowden JA, Veys P, Quartier P, Dalle JH, Dhooge C, Di Bartolomeo P, Gonzalez-Vicent M, Gibson B, Iriondo A, Juergens H, Lisukov I, Messina C, Mialou V, Steward CG, Urban C, Renard M, Giurici N, Peters C, Badoglio M, Ronfani L, Dini G, Farge D, Saccardi R; European Group for Blood and Marrow Transplantation Autoimmune Diseases and Paediatric Disease Working Parties.

Biol Blood Marrow Transplant. 2013 Apr;19(4):666-9. doi: 10.1016/j.bbmt.2012.12.008. Epub 2012 Dec 16.

11.

Prevalence of c-KIT mutations in gonadoblastoma and dysgerminomas of patients with disorders of sex development (DSD) and ovarian dysgerminomas.

Hersmus R, Stoop H, van de Geijn GJ, Eini R, Biermann K, Oosterhuis JW, Dhooge C, Schneider DT, Meijssen IC, Dinjens WN, Dubbink HJ, Drop SL, Looijenga LH.

PLoS One. 2012;7(8):e43952. doi: 10.1371/journal.pone.0043952. Epub 2012 Aug 28.

12.

Successful use of eculizumab in a pediatric patient treated for paroxysmal nocturnal hemoglobinuria.

Bauters T, Bordon V, Robays H, Benoit Y, Dhooge C.

J Pediatr Hematol Oncol. 2012 Nov;34(8):e346-8. doi: 10.1097/MPH.0b013e318258079a.

PMID:
22767128
13.

Incidence, kinetics, and risk factors of Epstein-Barr virus viremia in pediatric patients after allogeneic stem cell transplantation.

Bordon V, Padalko E, Benoit Y, Dhooge C, Laureys G.

Pediatr Transplant. 2012 Mar;16(2):144-50. doi: 10.1111/j.1399-3046.2011.01634.x. Epub 2012 Jan 31.

PMID:
22288846
14.

Vancomycin-induced red man syndrome in pediatric oncology: still an issue?

Bauters T, Claus B, Schelstraete P, Robays H, Benoit Y, Dhooge C.

Int J Clin Pharm. 2012 Feb;34(1):13-6. doi: 10.1007/s11096-011-9593-z. Epub 2011 Dec 13.

PMID:
22161495
15.

Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951.

De Moerloose B, Suciu S, Bertrand Y, Mazingue F, Robert A, Uyttebroeck A, Yakouben K, Ferster A, Margueritte G, Lutz P, Munzer M, Sirvent N, Norton L, Boutard P, Plantaz D, Millot F, Philippet P, Baila L, Benoit Y, Otten J; Children's Leukemia Group of the European Organisation for Research and Treatment of Cancer (EORTC).

Blood. 2010 Jul 8;116(1):36-44. doi: 10.1182/blood-2009-10-247965. Epub 2010 Apr 20.

16.

Constitutional translocation breakpoint mapping by genome-wide paired-end sequencing identifies HACE1 as a putative Wilms tumour susceptibility gene.

Slade I, Stephens P, Douglas J, Barker K, Stebbings L, Abbaszadeh F, Pritchard-Jones K; FACT collaboration, Cole R, Pizer B, Stiller C, Vujanic G, Scott RH, Stratton MR, Rahman N.

J Med Genet. 2010 May;47(5):342-7. doi: 10.1136/jmg.2009.072983. Epub 2009 Nov 30.

PMID:
19948536
17.

Prevention of wrong route errors in a pediatric hemato-oncology ward.

Bauters T, De Porre J, Janssens N, Van de Velde V, Verlooy J, Dhooge C, Robays H.

Pharm World Sci. 2009 Oct;31(5):522-4. doi: 10.1007/s11096-009-9319-7. Epub 2009 Aug 9.

PMID:
19669663
18.

Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause nonsyndromic Wilms tumor.

Scott RH, Douglas J, Baskcomb L, Huxter N, Barker K, Hanks S, Craft A, Gerrard M, Kohler JA, Levitt GA, Picton S, Pizer B, Ronghe MD, Williams D; Factors Associated with Childhood Tumours (FACT) Collaboration, Cook JA, Pujol P, Maher ER, Birch JM, Stiller CA, Pritchard-Jones K, Rahman N.

Nat Genet. 2008 Nov;40(11):1329-34. doi: 10.1038/ng.243. Epub 2008 Oct 5.

PMID:
18836444
19.

Surveillance of cytomegalovirus (CMV) DNAemia in pediatric allogeneic stem cell transplantation: incidence and outcome of CMV infection and disease.

Bordon V, Bravo S, Van Renterghem L, de Moerloose B, Benoit Y, Laureys G, Dhooge C.

Transpl Infect Dis. 2008 Feb;10(1):19-23. Epub 2007 May 19.

PMID:
17511814
20.

Distortion product otoacoustic emissions: an objective technique for the screening of hearing loss in children treated with platin derivatives.

Dhooge I, Dhooge C, Geukens S, De Clerck B, De Vel E, Vinck BM.

Int J Audiol. 2006 Jun;45(6):337-43.

PMID:
16777780

Supplemental Content

Loading ...
Support Center